Editors Claim Censorship at a Public Health Journal

The editorial board at the International Journal of Occupational and Environmental Health accuses its publisher of promoting corporate interests.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

© BRYAN SATALINOUpdate (November 22): The entire editorial board of the International Journal of Occupational and Environmental Health resigned today, RetractionWatch reports. “We have been unsatisfied with our interactions with you [Ian Bannerman, managing director at Taylor & Francis journals] and Taylor & Francis, especially regarding the appointment process for the new Editor-in-Chief, and the unilateral withdraw[al] of approved or printed articles done by the publishers,” board member Arthur Frank writes in a group resignation letter. “We do not wish to be party to the apparent new direction that the journal appears to be moving towards, and will not be party to these developments.”

All of the 22-member editorial board at the International Journal of Occupational and Environmental Health (IJOEH), eight former board members, and the founding editor-in-chief wrote to the National Library of Medicine (NLM) last week (November 16) with claims of censorship. Specifically, they accuse the journal’s publisher of taking strides to suppress the publication of articles that are unfriendly to industry products, effectively promoting “corporate interests over independent science in the public interest,” according to ProPublica.

IJOEH focuses on the risks of exposure to toxic chemicals and is known for publishing articles that take a critical look at industry-linked studies that proclaim the safety of a company’s products. In their letter, the former and current board members accused the publisher—the Taylor & Francis Group, which acquired ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies